tag:www.gov.uk,2005:/government/organisations/medicines-and-healthcare-products-regulatory-agencyMedicines and Healthcare products Regulatory Agency - Activity on 51²è¹ÝHM Government2025-05-15T10:30:20Z/drug-safety-update/thiopurines-and-intrahepatic-cholestasis-of-pregnancy#2025-05-15T10:30:20Z2025-05-15T10:30:20ZThiopurines and intrahepatic cholestasis of pregnancy Intrahepatic cholestasis of pregnancy (ICP) has been rarely reported in patients treated with azathioprine products and is believed to be a risk applicable to all drugs in the thiopurine class (azathioprine, mercaptopurine and tioguanine). Cholestasis of pregnancy associated with thiopurines tends to occur earlier in pregnancy than non drug-induced cholestasis of pregnancy, and elevated bile acid levels may not reduce with ursodeoxycholic acid. /guidance/register-a-homeopathic-medicine-or-remedy#2025-05-14T16:09:31Z2025-05-14T16:09:31ZRegister a homeopathic medicineInformation about how to register your homeopathic medicinal product through the Simplified Homeopathic Registration Scheme or the UK Homeopathic National Rules Scheme/government/publications/advertising-investigations-april-2025#2025-05-14T13:53:59Z2025-05-14T13:53:59ZDecision: Advertising Investigations: April 2025Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines./government/publications/medical-devices-given-exceptional-use-authorisations-during-the-covid-19-pandemic#2025-05-14T07:55:23Z2025-05-14T07:55:23ZDecision: Medical devices given exceptional use authorisations during the COVID-19 pandemicList of manufacturers and their medical devices granted an exemption by MHRA. The list also includes manufacturers whose exemption expired or was cancelled./drug-device-alerts/field-safety-notices-5-to-8-may-2025#2025-05-14T07:47:13Z2025-05-14T07:47:13ZField Safety Notices: 5 to 8 May 2025List of Field Safety Notices from 5 to 8 May 2025./government/publications/orphan-registered-medicinal-products#2025-05-13T11:26:11Z2025-05-13T11:26:11ZDecision: Orphan registered medicinal productsA list of authorised orphan medicinal products registered by the UK licensing authority./drug-device-alerts/class-4-medicines-notification-chemidex-pharma-ltd-various-products-el-25-a-slash-21#2025-05-13T10:00:04Z2025-05-13T10:00:04ZClass 4 Medicines Notification, Chemidex Pharma Ltd, Various Products, EL(25)A/21Chemidex Pharma Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in their topical steroid products does not contain all the required safety information. Cartons for the products/batches listed are missing side effect information related to Visual Disturbances. /government/publications/parallel-import-licences-granted-in-2025#2025-05-13T08:50:33Z2025-05-13T08:50:33ZDecision: Parallel import licences granted in 2025Parallel import licences granted in 2025./government/publications/international-recognition-procedure#2025-05-13T08:37:02Z2025-05-13T08:37:02ZGuidance: International Recognition ProcedureHow to use the procedure for medicines licensing applications./government/publications/marketing-authorisations-granted-in-2025#2025-05-13T08:36:22Z2025-05-13T08:36:22ZDecision: Marketing authorisations granted in 2025Marketing authorisations granted in 2025./government/news/meet-the-women-helping-ensure-that-digital-mental-health-technologies-are-safe-effective-and-developed-considering-the-needs-of-the-people-who-use-th#2025-05-12T23:00:00Z2025-05-12T23:00:00ZMeet the women helping ensure that digital mental health technologies are safe, effective and developed considering the needs of the people who use themMental health apps are everywhere, offering everything from mood tracking to therapy. But with so many options, how can people tell what these tools actually do?/government/news/mhra-approves-first-uk-treatment-for-congenital-thrombotic-thrombocytopenic-purpura-cttp#2025-05-12T16:41:15Z2025-05-12T16:41:15ZMHRA approves first UK treatment for congenital thrombotic thrombocytopenic purpura (cTTP) As with all products, the MHRA will keep its safety under close review./guidance/medicines-apply-for-a-parallel-import-licence#2025-05-12T15:22:24Z2025-05-12T15:22:24ZMedicines: apply for a parallel import licenceHow to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application. /government/consultations/consultation-on-the-international-council-for-harmonisation-ich-e6-r3-guideline-for-good-clinical-practice-annex-2#2025-05-12T13:25:48Z2025-05-12T13:25:48ZConsultation on the International Council for Harmonisation ICH E6 (R3) Guideline for Good Clinical Practice Annex-2The ICH Expert Working Group for ICH E6(R3) (EWG) has been updating the ICH E6(R2) GCP guideline. The MHRA represents the Pharmaceutical Inspection Co-operation Scheme (PIC/s) in the EWG./government/news/mhra-approves-worlds-first-low-carbon-version-of-copd-inhaler-trixeo-aerosphere#2025-05-12T04:17:30Z2025-05-12T04:17:30ZMHRA approves world’s first low-carbon version of COPD inhaler Trixeo AerosphereAs with all medicines, the MHRA will continue to monitor the safety and effectiveness of Trixeo Aerosphere/government/publications/the-northern-ireland-mhra-authorised-route-nimar#2025-05-09T10:14:01Z2025-05-09T10:14:01ZGuidance: The Northern Ireland MHRA Authorised Route (NIMAR)The UK government has introduced the Northern Ireland MHRA Authorised Route (NIMAR). This new route for supply became operational 1 January 2022. /government/consultations/consultation-on-the-international-council-for-harmonisation-ich-m13b-guideline-on-bioequivalence-for-immediate-release-solid-oral-dosage-forms#2025-05-08T23:01:00Z2025-05-08T23:01:00ZConsultation on the International Council for Harmonisation (ICH) M13B Guideline on Bioequivalence for Immediate-Release Solid Oral Dosage FormsThe ICH Expert Working Group (EWG) for ICH M13B has been drafting the second guideline in the series which describes the scientific and technical aspects of study design and data analysis to support bioequivalence (BE) assessment for orally administered immediate-release solid oral dosage forms./government/publications/medicines-and-healthcare-products-regulatory-agency-gpc-spending-over-500-2024-25#2025-05-08T16:23:57Z2025-05-08T16:23:57ZTransparency data: Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2024-25MHRA transactions over £500 made using the government procurement card (GPC)./government/publications/medicines-and-healthcare-products-regulatory-agency-gpc-spending-over-500-2023-24#2025-05-08T16:23:56Z2025-05-08T16:23:56ZTransparency data: Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2023-24MHRA transactions over £500 made using the government procurement card (GPC)./government/publications/medicines-and-healthcare-products-regulatory-agency-gpc-spending-over-500-2022-23#2025-05-08T16:23:55Z2025-05-08T16:23:55ZTransparency data: Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2022-23MHRA transactions over £500 made using the government procurement card (GPC).